11:11 AM EDT, 04/01/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were treading water late Tuesday morning, edging 0.02% higher to 1,397.86 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by medical device maker EDAP TMS ( EDAP ) and telecommunications company Nokia ( NOK ) , which were up 2.4% and 1.6% respectively. They were followed by petroleum refiner Equinor ( EQNR ) and financial services company Banco Santander (SAN), which increased 1.4% and 1.1% respectively.

The decliners from continental Europe were led by biotech firm Evaxion Biotech ( EVAX ) and biopharmaceutical company DBV Technologies ( DBVT ) , which shed 10% and 8.7% respectively. They were followed by biopharmaceutical company Genfit ( GNFT ) and pharmaceutical company Ascendis Pharma ( ASND ) , which lost 3.3% and 2.4% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies NuCana ( NCNA ) and Adaptimmune Therapeutics ( ADAP ) , which rose 8.2% and 6.9% respectively. They were followed by biotech firm Trinity Biotech ( TRIB ) and biopharmaceutical company Akari Therapeutics ( AKTX ) , which advanced 5% and 3.2% respectively.

The decliners from the UK and Ireland were led by communications company WPP ( WPP ) and biopharmaceutical company Bicycle Therapeutics ( BCYC ) , which dropped 5.7% and 4.2% respectively. They were followed by biotech firm Autolus Therapeutics ( AUTL ) and pharmaceutical company Silence Therapeutics ( SLN ) , which were down 3.6% and 3.5% respectively.